QC
IRWD icon

Quantedge Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Quantedge Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17,400
Closed -$199K – 124
2023
Q4 		$199K Sell
17,400
-162,500
-90% -$1.61M 0.1% 99
2023
Q3 		$1.73M Sell
179,900
-282,000
-61% -$2.76M 0.94% 33
2023
Q2 		$4.91M Sell
461,900
-79,300
-15% -$852K 2.19% 13
2023
Q1 		$5.69M Buy
541,200
+190,500
+54% +$2.13M 2.22% 8
2022
Q4 		$4.35M Buy
350,700
+47,700
+16% +$541K 1.46% 16
2022
Q3 		$3.14M Buy
303,000
+122,700
+68% +$1.39M 0.97% 34
2022
Q2 		$2.08M Buy
+180,300
New +$2.12M 0.42% 81

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Quantedge Capital's IRWD Position: Q1 2024 in Review

Quantedge Capital sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2024, closing a stake of 17,400 shares — an estimated $199K sold.

Quantedge Capital first reported a position in IRWD in Q2 2022 and held it in 7 quarters. The position peaked at $5.69M in Q1 2023. 261 funds tracked by Wall St. Rank hold IRWD as of Q1 2024.

  • Quantedge Capital reported no remaining Ironwood Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Quantedge Capital sold 17,400 Ironwood Pharmaceuticals shares in Q1 2024, an estimated $199K.
  • Quantedge Capital first reported a position in Ironwood Pharmaceuticals in Q2 2022 and held it in 7 quarters.
  • Quantedge Capital's Ironwood Pharmaceuticals position peaked at $5.69M in Q1 2023.
  • 261 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2024.

Based on Quantedge Capital's 13F filing for Q1 2024, filed 14 May 2024.